OBJECTIVES: A recent linkage analysis of 360 families at high risk for prostate cancer identified the q27-28 region on chromosome X as the potential location of a gene involved in prostate cancer susceptibility. Here we report on linkage analysis at this putative HPCX locus in an independent set of 186 prostate cancer families participating in the Prostate Cancer Genetic Research Study (PROGRESS). METHODS: DNA samples from these families were genotyped at 8 polymorphic markers spanning 14.3 cM of the HPCX region. RESULTS: Two-point parametric analysis of the total data set resulted in positive lod scores at only two markers, DXS984 and DXS1193, with scores of 0.628 at a recombination fraction (theta) of 0.36 and 0.012 at theta = 0.48, respectively. The stratification of pedigrees according to the assumed mode of transmission increased the evidence of linkage at DXS984 in 81 families with no evidence of male-to-male transmission (lod = 1.062 at theta = 0.28). CONCLUSIONS: Although this analysis did not show statistically significant evidence for the linkage of prostate cancer susceptibility to Xq27-28, the results are consistent with a small percentage of families being linked to this region. The analysis further highlights difficulties in replicating linkage results in an etiologically heterogeneous, complexly inherited disease. Copyright 2000 S. Karger AG, Basel.
OBJECTIVES: A recent linkage analysis of 360 families at high risk for prostate cancer identified the q27-28 region on chromosome X as the potential location of a gene involved in prostate cancer susceptibility. Here we report on linkage analysis at this putative HPCX locus in an independent set of 186 prostate cancer families participating in the Prostate Cancer Genetic Research Study (PROGRESS). METHODS: DNA samples from these families were genotyped at 8 polymorphic markers spanning 14.3 cM of the HPCX region. RESULTS: Two-point parametric analysis of the total data set resulted in positive lod scores at only two markers, DXS984 and DXS1193, with scores of 0.628 at a recombination fraction (theta) of 0.36 and 0.012 at theta = 0.48, respectively. The stratification of pedigrees according to the assumed mode of transmission increased the evidence of linkage at DXS984 in 81 families with no evidence of male-to-male transmission (lod = 1.062 at theta = 0.28). CONCLUSIONS: Although this analysis did not show statistically significant evidence for the linkage of prostate cancer susceptibility to Xq27-28, the results are consistent with a small percentage of families being linked to this region. The analysis further highlights difficulties in replicating linkage results in an etiologically heterogeneous, complexly inherited disease. Copyright 2000 S. Karger AG, Basel.
Authors: M Gibbs; J L Stanford; G P Jarvik; M Janer; M Badzioch; M A Peters; E L Goode; S Kolb; L Chakrabarti; M Shook; R Basom; E A Ostrander; L Hood Journal: Am J Hum Genet Date: 2000-05-19 Impact factor: 11.025
Authors: Danielle M Friedrichsen; Janet L Stanford; Sarah D Isaacs; Marta Janer; Bao-Li Chang; Kerry Deutsch; Elizabeth Gillanders; Suzanne Kolb; Katherine E Wiley; Michael D Badzioch; S Lilly Zheng; Patrick C Walsh; Gail P Jarvik; Leroy Hood; Jeffrey M Trent; William B Isaacs; Elaine A Ostrander; Jianfeng Xu Journal: Proc Natl Acad Sci U S A Date: 2004-02-09 Impact factor: 11.205
Authors: James M Farnham; Nicola J Camp; Jeff Swensen; Sean V Tavtigian; Lisa A Cannon Albright Journal: Hum Genet Date: 2004-12-08 Impact factor: 4.132
Authors: J Xu; S L Zheng; J D Carpten; N N Nupponen; C M Robbins; J Mestre; T Y Moses; D A Faith; B D Kelly; S D Isaacs; K E Wiley; C M Ewing; P Bujnovszky; B Chang ; J Bailey-Wilson; E R Bleecker; P C Walsh; J M Trent; D A Meyers; W B Isaacs Journal: Am J Hum Genet Date: 2001-03-14 Impact factor: 11.025
Authors: Agnes B Baffoe-Bonnie; Jeffrey R Smith; Dietrich A Stephan; Johanna Schleutker; John D Carpten; Tommi Kainu; Elizabeth M Gillanders; Mika Matikainen; Tanya M Teslovich; Teuvo Tammela; Raman Sood; Andrew M Balshem; Sheehan D Scarborough; Jianfeng Xu; William B Isaacs; Jeffrey M Trent; Olli-P Kallioniemi; Joan E Bailey-Wilson Journal: Hum Genet Date: 2005-05-20 Impact factor: 4.132
Authors: Ilir Agalliu; Suzanne M Leanza; Lorie Smith; Jeffrey M Trent; John D Carpten; Joan E Bailey-Wilson; Robert D Burk Journal: Prostate Date: 2010-11-01 Impact factor: 4.104
Authors: Joan E Bailey-Wilson; Erica J Childs; Cheryl D Cropp; Daniel J Schaid; Jianfeng Xu; Nicola J Camp; Lisa A Cannon-Albright; James M Farnham; Asha George; Isaac Powell; John D Carpten; Graham G Giles; John L Hopper; Gianluca Severi; Dallas R English; William D Foulkes; Lovise Mæhle; Pål Møller; Rosalind Eeles; Douglas Easton; Michelle Guy; Steve Edwards; Michael D Badzioch; Alice S Whittemore; Ingrid Oakley-Girvan; Chih-Lin Hsieh; Latchezar Dimitrov; Janet L Stanford; Danielle M Karyadi; Kerry Deutsch; Laura McIntosh; Elaine A Ostrander; Kathleen E Wiley; Sarah D Isaacs; Patrick C Walsh; Stephen N Thibodeau; Shannon K McDonnell; Scott Hebbring; Ethan M Lange; Kathleen A Cooney; Teuvo L J Tammela; Johanna Schleutker; Christiane Maier; Sylvia Bochum; Josef Hoegel; Henrik Grönberg; Fredrik Wiklund; Monica Emanuelsson; Geraldine Cancel-Tassin; Antoine Valeri; Olivier Cussenot; William B Isaacs Journal: BMC Med Genet Date: 2012-06-19 Impact factor: 2.103